Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yingyi Mei"'
Autor:
Yusheng Ou, Min Liu, Kai Zhan, Wanli Wu, Jiao Huang, Hanli Sun, Hongjun Zheng, Xiaohong Yu, Haiping Gong, Zhaosheng Han, Aiyuan Chen, Youping Liao, Yanmei Lin, Ge Liu, Qiuping Liu, Ruijuan Ma, Yingyi Mei, Xianqing Tang, Zhiming Weng, Jieyi Wu, Yun Ye, Tingting Zhang, Jiehong Chen, Lin Chen, Qingfeng Ding, Hui Fan, Jiajia Hu, Jinhua Huang, Lihong Huang, Qiaowei Li, Siyun Li, Jia Shi, Xiangpeng Tan, Xiaoling Wang, Ruirui Xiang, Qingjia Yan, Jianbin Zhang, Wenjing Zheng, Shi Zhong
The clinical success of T-cell receptor (TCR)-based immunotherapy depends on the efficacy and specificity of TCRs. Naturally occurring TCRs have limited anti-tumor potency due to their low affinity for tumor antigens. Affinity enhancement is a promis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6c3e6cdc0ad2a2c53ccfd2635e59dff
https://doi.org/10.1101/2022.10.12.511904
https://doi.org/10.1101/2022.10.12.511904
Autor:
Yaolong Chen, Yi Li, Wu Wanli, Zhenjuan Li, Gong Haiping, Yingyi Mei, Yu Xiaohong, Jianting Cheng, Shi Zhong, Liu Qiuping, Hongjun Zheng
Publikováno v:
Immunology
Hepatocellular carcinoma (HCC) is the most common type of liver cancer with limited treatments. Asia has the highest HCC incidence rates; China accounts for over 50% of all HCC cases worldwide. T‐cell receptor (TCR) ‐engineered T‐cell immunothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a85f4bd178fb7cda487fe8d03cee8503
https://europepmc.org/articles/PMC7078006/
https://europepmc.org/articles/PMC7078006/
Publikováno v:
Wei sheng wu xue bao = Acta microbiologica Sinica. 56(5)
To study the immunological cross-reactivity and cross-protection characteristics of OmpU in Vibrio species.The ompU genes from 10 Vibrio strains were cloned, sequenced, followed by bioinformatics analysis. Western blot and whole-cell ELISA assay were